Previous Close | 1.3300 |
Open | 1.3400 |
Bid | 0.9000 |
Ask | 1.4900 |
Strike | 35.00 |
Expire Date | 2025-11-21 |
Day's Range | 1.3400 - 1.4000 |
Contract Range | N/A |
Volume | |
Open Interest | 393 |
RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for treating MBC.
As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.